Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

LDMBI

Financiado

Cerrado

Low dose Molecular Breast Imaging for improved cancer detection in dense breast...

Low dose Molecular Breast Imaging for improved cancer detection in dense breast tissue. The 50% of women with dense breast tissue who are currently screened for breast cancer by mammography have large numbers of cancers missed, and non-cancerous features erroneously diagnosed, due to the difficulty of a mammogram dis... ver más

31/08/2016

Kromek Ltd

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

KROMEK LIMITED No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2016-08-31

PHC-12-2015-1: Clinical research for the validatio...

I+D

Cerrada hace 9 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

Kromek Ltd

50.00K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

OE Scan A next generation diagnostic device that effectively screens... 71K€ Cerrado

MAMMOCARE Breast biopsy system guided by Positron Emission Mammography... 1M€ Cerrado

SCARtool Scattered radiation reduction tool to improve computer aided... 158K€ Cerrado

RTI2018-096333-B-I00 COMPUTACION DE LA IMAGEN PARA LA MEJORA DE LA RADIOMICA DEL... 150K€ Cerrado

CADe4BMRI Improved detection and characterisation of breast cancer usi... 88K€ Cerrado

MammoWave Cutting edge microwave imaging device for safe and accurate... 2M€ Cerrado

Duración del proyecto: 6 meses Fecha Inicio: 2016-02-25
Fecha Fin: 2016-08-31

Líder del proyecto

KROMEK LIMITED No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The 50% of women with dense breast tissue who are currently screened for breast cancer by mammography have large numbers of cancers missed, and non-cancerous features erroneously diagnosed, due to the difficulty of a mammogram distinguishing tumours from dense breast tissue. In dense breasts, around 1 in 2 cancers is missed by mammography. Molecular Breast Imaging has much higher sensitivity (a better cancer detection rate) and specificity (fewer false alarms) than mammography, particularly for dense breasts. Its use as a screening technology is currently restricted due to its high radiation dose and inability to guide a biopsy. This feasibility study will investigate the technical, economic and regulatory viability of Kromek’s technology to being adopted in optimised diagnosis pathways. Kromek currently supplies detectors into the MBI market, and have a number of innovative platform technologies to add to the current offering to create a system to address these barriers to adoption. Work in this Phase 1 study will identify the dose vs cancer detection balance, to guide the application of the technologies to the market needs. We predict sales in the EU and USA of 147 million Euros in the first five years after commercialisation, which will help address the approximately 110 thousand women in Europe whose cancers in dense breasts are currently missed by mammography.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores